Cargando…

AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study

BACKGROUND: Most hepatocellular carcinoma (HCC) patients’ liver function indexes are abnormal. We aimed to investigate the relationship between (alkaline phosphatase + gamma-glutamyl transpeptidase)/lymphocyte ratio (AGLR) and the progression as well as the prognosis of HCC. METHODS: A total of 495...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Yan, Wei, Rongyu, Yao, Renzhi, Qin, Liling, Li, Jun, Yu, Junxiong, Liao, Weijia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860009/
https://www.ncbi.nlm.nih.gov/pubmed/33536005
http://dx.doi.org/10.1186/s12893-020-01037-7
_version_ 1783646853055643648
author Liao, Yan
Wei, Rongyu
Yao, Renzhi
Qin, Liling
Li, Jun
Yu, Junxiong
Liao, Weijia
author_facet Liao, Yan
Wei, Rongyu
Yao, Renzhi
Qin, Liling
Li, Jun
Yu, Junxiong
Liao, Weijia
author_sort Liao, Yan
collection PubMed
description BACKGROUND: Most hepatocellular carcinoma (HCC) patients’ liver function indexes are abnormal. We aimed to investigate the relationship between (alkaline phosphatase + gamma-glutamyl transpeptidase)/lymphocyte ratio (AGLR) and the progression as well as the prognosis of HCC. METHODS: A total of 495 HCC patients undergoing radical hepatectomy were retrospectively analyzed. We randomly divided these patients into the training cohort (n = 248) and the validation cohort (n = 247). In the training cohort, receiver operating characteristic (ROC) curve was used to determine the optimal cut-off value of AGLR for predicting postoperative survival of HCC patients, and the predictive value of AGLR was evaluated by concordance index (C-index). Further analysis of clinical and biochemical data of patients and the correlation analysis between AGLR and other clinicopathological factors were finished. Univariate and multivariate analyses were performed to identify prognostic factors for HCC patients. Survival curves were analyzed using the Kaplan–Meier method. RESULTS: According to the ROC curve analysis, the optimal predictive cut-off value of AGLR was 90. The C-index of AGLR was 0.637 in the training cohort and 0.654 in the validation cohort, respectively. Based on this value, the HCC patients were divided into the low-AGLR group (AGLR ≤ 90) and the high-AGLR group (AGLR > 90). Preoperative AGLR level was positively correlated with alpha-fetoprotein (AFP), tumor size, tumor-node-metastasis (TNM) stage, and microvascular invasion (MVI) (all p < 0.05). In the training and validation cohorts, patients with AGLR > 90 had significantly shorter OS than patients with AGLR ≤ 90 (p < 0.001). Univariate and multivariate analyses of the training cohort (HR, 1.79; 95% CI 1.21–2.69; p < 0.001) and validation cohort (HR, 1.82; 95% CI 1.35–2.57; p < 0.001) had identified AGLR as an independent prognostic factor. A new prognostic scoring model was established based on the independent predictors determined in multivariate analysis. CONCLUSIONS: The elevated preoperative AGLR level indicated poor prognosis for patients with HCC; the novel prognostic scoring model had favorable predictive capability for postoperative prognosis of HCC patients, which may bring convenience for clinical management.
format Online
Article
Text
id pubmed-7860009
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78600092021-02-04 AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study Liao, Yan Wei, Rongyu Yao, Renzhi Qin, Liling Li, Jun Yu, Junxiong Liao, Weijia BMC Surg Research Article BACKGROUND: Most hepatocellular carcinoma (HCC) patients’ liver function indexes are abnormal. We aimed to investigate the relationship between (alkaline phosphatase + gamma-glutamyl transpeptidase)/lymphocyte ratio (AGLR) and the progression as well as the prognosis of HCC. METHODS: A total of 495 HCC patients undergoing radical hepatectomy were retrospectively analyzed. We randomly divided these patients into the training cohort (n = 248) and the validation cohort (n = 247). In the training cohort, receiver operating characteristic (ROC) curve was used to determine the optimal cut-off value of AGLR for predicting postoperative survival of HCC patients, and the predictive value of AGLR was evaluated by concordance index (C-index). Further analysis of clinical and biochemical data of patients and the correlation analysis between AGLR and other clinicopathological factors were finished. Univariate and multivariate analyses were performed to identify prognostic factors for HCC patients. Survival curves were analyzed using the Kaplan–Meier method. RESULTS: According to the ROC curve analysis, the optimal predictive cut-off value of AGLR was 90. The C-index of AGLR was 0.637 in the training cohort and 0.654 in the validation cohort, respectively. Based on this value, the HCC patients were divided into the low-AGLR group (AGLR ≤ 90) and the high-AGLR group (AGLR > 90). Preoperative AGLR level was positively correlated with alpha-fetoprotein (AFP), tumor size, tumor-node-metastasis (TNM) stage, and microvascular invasion (MVI) (all p < 0.05). In the training and validation cohorts, patients with AGLR > 90 had significantly shorter OS than patients with AGLR ≤ 90 (p < 0.001). Univariate and multivariate analyses of the training cohort (HR, 1.79; 95% CI 1.21–2.69; p < 0.001) and validation cohort (HR, 1.82; 95% CI 1.35–2.57; p < 0.001) had identified AGLR as an independent prognostic factor. A new prognostic scoring model was established based on the independent predictors determined in multivariate analysis. CONCLUSIONS: The elevated preoperative AGLR level indicated poor prognosis for patients with HCC; the novel prognostic scoring model had favorable predictive capability for postoperative prognosis of HCC patients, which may bring convenience for clinical management. BioMed Central 2021-02-03 /pmc/articles/PMC7860009/ /pubmed/33536005 http://dx.doi.org/10.1186/s12893-020-01037-7 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Liao, Yan
Wei, Rongyu
Yao, Renzhi
Qin, Liling
Li, Jun
Yu, Junxiong
Liao, Weijia
AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study
title AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study
title_full AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study
title_fullStr AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study
title_full_unstemmed AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study
title_short AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study
title_sort aglr is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860009/
https://www.ncbi.nlm.nih.gov/pubmed/33536005
http://dx.doi.org/10.1186/s12893-020-01037-7
work_keys_str_mv AT liaoyan aglrisanovelindexfortheprognosisofhepatocellularcarcinomapatientsaretrospectivestudy
AT weirongyu aglrisanovelindexfortheprognosisofhepatocellularcarcinomapatientsaretrospectivestudy
AT yaorenzhi aglrisanovelindexfortheprognosisofhepatocellularcarcinomapatientsaretrospectivestudy
AT qinliling aglrisanovelindexfortheprognosisofhepatocellularcarcinomapatientsaretrospectivestudy
AT lijun aglrisanovelindexfortheprognosisofhepatocellularcarcinomapatientsaretrospectivestudy
AT yujunxiong aglrisanovelindexfortheprognosisofhepatocellularcarcinomapatientsaretrospectivestudy
AT liaoweijia aglrisanovelindexfortheprognosisofhepatocellularcarcinomapatientsaretrospectivestudy